Healthcare Global Enterprises Ltd

AI
Health.Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Healthcare Global Enterprises Ltd

₹ 566 -3.88%
11 Nov - close price
hcgoncology.com BSE: 539787 NSE: HCG
About

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

Key Points

Service Offering
HCG provides integrated cancer care covering diagnosis, medical oncology (chemotherapy, immunotherapy and targeted therapies), surgical oncology, radiation therapy, bone marrow transplantation and follow-up care. The network adopts an organ-specific, multidisciplinary approach through tumour boards, combining specialist doctors, clinical protocols and advanced technology for complex cancer treatment.[1]

Website BSE NSE
  • Market Cap ₹ 8,442 Cr.
  • Current Price ₹ 566
  • High / Low ₹ 775 / 513
  • Stock P/E 213
  • Book Value ₹ 90.3
  • Dividend Yield 0.00 %
  • ROCE 8.30 %
  • ROE 2.54 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 6.25 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 4.24% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.09%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty Microcap 250 Nifty Total Market BSE 1000 BSE Hospitals Nifty Smallcap 500

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
486.94 469.87 494.63 525.58 553.54 558.57 585.16 613.16 646.85 633.07 652.33 695.10 731.80
402.32 391.26 402.60 434.68 451.30 470.19 479.53 505.37 523.54 523.51 527.25 572.84 598.41
Operating Profit 84.62 78.61 92.03 90.90 102.24 88.38 105.63 107.79 123.31 109.56 125.08 122.26 133.39
OPM % 17.38% 16.73% 18.61% 17.30% 18.47% 15.82% 18.05% 17.58% 19.06% 17.31% 19.17% 17.59% 18.23%
3.40 6.07 9.01 8.81 11.13 5.54 10.23 7.51 2.93 -10.20 -18.32 13.06 -8.68
Interest 26.89 29.46 26.84 33.71 35.98 40.70 44.17 45.47 43.62 44.78 42.70 39.87 38.42
Depreciation 43.21 44.16 45.98 47.01 49.74 56.52 58.07 57.91 62.80 60.65 62.81 70.42 67.80
Profit before tax 17.92 11.06 28.22 18.99 27.65 -3.30 13.62 11.92 19.82 -6.07 1.25 25.03 18.49
Tax % 39.84% 68.99% 16.87% 28.23% 25.21% -334.85% 50.29% 49.83% -4.24% 30.15% -223.20% 34.24% 49.97%
10.78 3.43 23.46 13.63 20.68 7.75 6.77 5.98 20.66 -7.90 4.04 16.46 9.25
EPS in Rs 0.97 0.41 1.52 0.86 1.28 0.50 0.52 0.34 1.15 -0.66 0.15 0.92 0.32
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
519 584 700 829 976 1,092 1,009 1,395 1,691 1,908 2,218 2,538 2,712
443 499 595 713 864 936 887 1,161 1,394 1,581 1,835 2,080 2,222
Operating Profit 76 85 105 116 112 157 122 234 297 327 384 459 490
OPM % 15% 15% 15% 14% 11% 14% 12% 17% 18% 17% 17% 18% 18%
0 -2 10 25 10 10 -72 110 15 24 39 -11 -24
Interest 34 38 23 42 70 138 119 98 104 109 155 177 166
Depreciation 39 44 57 71 85 148 159 158 163 174 211 244 262
Profit before tax 3 0 35 27 -33 -119 -229 88 45 68 57 27 39
Tax % -56% -730% 34% 38% -7% 5% -3% 56% 61% 39% 14% 15%
5 2 23 17 -31 -125 -221 39 18 41 49 23 22
EPS in Rs 0.12 -0.17 2.57 2.35 -2.80 -11.96 -15.34 3.84 2.10 3.44 3.17 0.92 0.73
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 16%
5 Years: 20%
3 Years: 14%
TTM: 13%
Compounded Profit Growth
10 Years: 39%
5 Years: 18%
3 Years: -1%
TTM: 12%
Stock Price CAGR
10 Years: 9%
5 Years: 17%
3 Years: 15%
1 Year: -24%
Return on Equity
10 Years: -1%
5 Years: 4%
3 Years: 4%
Last Year: 3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 70 85 86 87 88 89 125 139 139 139 139 149 149
Reserves 210 341 347 428 389 293 572 731 721 686 783 1,183 1,199
349 324 420 464 658 1,347 977 915 901 1,274 1,837 1,735 1,609
147 294 372 461 515 518 357 433 549 601 780 853 772
Total Liabilities 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,311 2,701 3,540 3,920 3,730
528 583 685 828 970 1,646 1,382 1,547 1,553 1,758 2,442 2,462 2,580
CWIP 42 121 148 174 153 46 30 22 18 83 25 19 24
Investments 0 64 11 53 49 34 26 9 10 10 11 14 16
205 275 381 385 478 520 593 641 730 850 1,062 1,426 1,109
Total Assets 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,311 2,701 3,540 3,920 3,730

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
60 73 91 98 98 130 121 220 252 285 317 347
-79 -204 -210 -283 -238 -101 -171 125 -133 -226 -488 -177
22 216 89 161 84 -58 112 -155 -140 -64 -42 241
Net Cash Flow 2 85 -29 -24 -56 -30 62 190 -22 -5 -213 410
Free Cash Flow -20 -137 -101 -158 -90 23 85 150 126 101 110 59
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 87% 99% 93% 88% 121% 100% 68% 104% 92% 101% 91% 83%

Ratios

Consolidated / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 45 43 54 57 59 62 67 57 65 56 66 60
Inventory Days 36 32 40 46 45 35 32 31 33 33 33 32
Days Payable 208 264 272 274 303 234 221 199 214 216 210 185
Cash Conversion Cycle -127 -188 -178 -171 -200 -136 -121 -112 -116 -127 -111 -93
Working Capital Days -65 -96 -112 -74 -110 -102 -26 -43 -40 -70 -91 -61
ROCE % 7% 6% 7% 6% 3% 1% -1% 5% 8% 9% 9% 8%

Insights

In beta
Mar 2010 Mar 2015 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Average Occupancy Rate (AOR)
%

Log in to view insights

Please log in to see hidden values.

Login
Number of LINACs
LINACs
Capacity Beds (Installed)
Beds
Number of Hospitals
Hospitals
Operating Theatres
OTs
Operational Beds
Beds
ARPP (Average Revenue Per Patient, excl Fertility)
INR per patient
IP Patient Volumes (excl Fertility)
IP patients

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
71.29% 71.28% 71.26% 71.23% 71.22% 71.22% 62.46% 63.78% 63.77% 64.21% 64.21% 64.21%
6.37% 6.74% 3.95% 4.30% 2.77% 2.44% 2.16% 3.59% 3.22% 2.76% 2.73% 2.70%
8.46% 8.52% 10.89% 11.64% 12.94% 12.48% 13.22% 18.36% 18.30% 18.91% 19.20% 20.78%
13.89% 13.45% 13.90% 12.84% 13.07% 13.86% 22.17% 14.28% 14.71% 14.15% 13.86% 12.32%
No. of Shareholders 27,28927,19526,52929,67032,82045,39447,02846,97045,36647,64948,90544,774

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls